Phagenesis
Phagenesis is developing a device for the treatment for dysphagia, the inability to swallow safely, that often accompanies stroke or other neuro-deficit diseases. The approach is to harness the brain's own capacity for relearning functions that have been lost through brain damage (via "neuroplasticity" or "cortical remapping"). Focusing initially on the care of stroke patients as they recover in hospital (acute care), Prof Shaheen Hamdy of the University of Manchester, UK, painstakingly devised a method of delivering electrical signals from the pharynx (throat) along nerve cells directly to the relevant parts of the brain. The results of his work have been published in top peer-reviewed scientific and medical journals, including The Lancet, the Nature group of publications, and Gastroenterology.
Domain
phagenesis.com
Country
United KingdomIndustry
BiotechnologyEmployees
11-50
Last Funding
$42.0M
Founded
2006
Tech Stack (28 technologies)
Frequently Asked Questions
What technologies does Phagenesis use?+
Phagenesis uses 28 technologies including Facebook Pixel, Google Analytics, Google Tag Manager.
What industry is Phagenesis in?+
Phagenesis operates in the Biotechnology industry.
Where is Phagenesis based?+
Phagenesis is headquartered in United Kingdom.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: July 2026